πŸ‡ΊπŸ‡Έ FDA
Patent

US 8426458

Hepatitis C Virus inhibitors

granted A61KA61K31/4178A61K31/444

Quick answer

US patent 8426458 (Hepatitis C Virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4178, A61K31/444, A61K31/4545, A61K31/496